Personal digital assistant-based drug information sources

Potential to improve medication safety

Kimberly A. Galt, Ann M. Rule, Bruce Houghton, Daniel O. Young, Gina Remington

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Objectives: This study compared the potential for personal digital assistant (PDA)-based drug information sources to minimize potential medication errors dependent on accurate and complete drug information at the point of care. Methods: A quality and safety framework for drug information resources was developed to evaluate 11 PDA-based drug information sources. Three drug information sources met the criteria of the framework: Eprocrates Rx Pro, Lexi-Drugs, and mobileMICROMEDEX. Medication error types related to drug information at the point of care were then determined. Forty-seven questions were developed to test the potential of the sources to prevent these error types. Pharmacists and physician experts from Creighton University created these questions based on the most common types of questions asked by primary care providers. Three physicians evaluated the drug information sources, rating the source for each question: 1 = no information available, 2 = some information available, or 3 = adequate amount of information available. Results: The mean ratings for the drug information sources were: 2.0 (Eprocrates Rx Pro), 2.5 (Lexi-Drugs), and 2.03 (mobileMICROMEDEX). Lexi-Drugs was significantly better (mobileMICROMEDEX t test; P = 0.05; Eprocrates Rx Pro t test; P = 0.01). Conclusion: Lexi-Drugs was found to be the most specific and complete PDA resource available to optimize medication safety by reducing potential errors associated with drug information. No resource was sufficient to address the patient safety information needs for all cases.

Original languageEnglish
Pages (from-to)229-236
Number of pages8
JournalJournal of the Medical Library Association : JMLA
Volume93
Issue number2
StatePublished - Apr 2005

Fingerprint

Handheld Computers
assistant
medication
drug
Safety
Pharmaceutical Preparations
Point-of-Care Systems
available information
Medication Errors
rating
physician
Physicians
resources
Prodrugs
Patient Safety
pharmacist
Pharmacists
Primary Health Care

All Science Journal Classification (ASJC) codes

  • Library and Information Sciences

Cite this

Personal digital assistant-based drug information sources : Potential to improve medication safety. / Galt, Kimberly A.; Rule, Ann M.; Houghton, Bruce; Young, Daniel O.; Remington, Gina.

In: Journal of the Medical Library Association : JMLA, Vol. 93, No. 2, 04.2005, p. 229-236.

Research output: Contribution to journalArticle

Galt, Kimberly A. ; Rule, Ann M. ; Houghton, Bruce ; Young, Daniel O. ; Remington, Gina. / Personal digital assistant-based drug information sources : Potential to improve medication safety. In: Journal of the Medical Library Association : JMLA. 2005 ; Vol. 93, No. 2. pp. 229-236.
@article{816dc4a4281c45309b06c4c0cf281bf4,
title = "Personal digital assistant-based drug information sources: Potential to improve medication safety",
abstract = "Objectives: This study compared the potential for personal digital assistant (PDA)-based drug information sources to minimize potential medication errors dependent on accurate and complete drug information at the point of care. Methods: A quality and safety framework for drug information resources was developed to evaluate 11 PDA-based drug information sources. Three drug information sources met the criteria of the framework: Eprocrates Rx Pro, Lexi-Drugs, and mobileMICROMEDEX. Medication error types related to drug information at the point of care were then determined. Forty-seven questions were developed to test the potential of the sources to prevent these error types. Pharmacists and physician experts from Creighton University created these questions based on the most common types of questions asked by primary care providers. Three physicians evaluated the drug information sources, rating the source for each question: 1 = no information available, 2 = some information available, or 3 = adequate amount of information available. Results: The mean ratings for the drug information sources were: 2.0 (Eprocrates Rx Pro), 2.5 (Lexi-Drugs), and 2.03 (mobileMICROMEDEX). Lexi-Drugs was significantly better (mobileMICROMEDEX t test; P = 0.05; Eprocrates Rx Pro t test; P = 0.01). Conclusion: Lexi-Drugs was found to be the most specific and complete PDA resource available to optimize medication safety by reducing potential errors associated with drug information. No resource was sufficient to address the patient safety information needs for all cases.",
author = "Galt, {Kimberly A.} and Rule, {Ann M.} and Bruce Houghton and Young, {Daniel O.} and Gina Remington",
year = "2005",
month = "4",
language = "English",
volume = "93",
pages = "229--236",
journal = "Journal of the Medical Library Association : JMLA",
issn = "1536-5050",
publisher = "Medical Library Association",
number = "2",

}

TY - JOUR

T1 - Personal digital assistant-based drug information sources

T2 - Potential to improve medication safety

AU - Galt, Kimberly A.

AU - Rule, Ann M.

AU - Houghton, Bruce

AU - Young, Daniel O.

AU - Remington, Gina

PY - 2005/4

Y1 - 2005/4

N2 - Objectives: This study compared the potential for personal digital assistant (PDA)-based drug information sources to minimize potential medication errors dependent on accurate and complete drug information at the point of care. Methods: A quality and safety framework for drug information resources was developed to evaluate 11 PDA-based drug information sources. Three drug information sources met the criteria of the framework: Eprocrates Rx Pro, Lexi-Drugs, and mobileMICROMEDEX. Medication error types related to drug information at the point of care were then determined. Forty-seven questions were developed to test the potential of the sources to prevent these error types. Pharmacists and physician experts from Creighton University created these questions based on the most common types of questions asked by primary care providers. Three physicians evaluated the drug information sources, rating the source for each question: 1 = no information available, 2 = some information available, or 3 = adequate amount of information available. Results: The mean ratings for the drug information sources were: 2.0 (Eprocrates Rx Pro), 2.5 (Lexi-Drugs), and 2.03 (mobileMICROMEDEX). Lexi-Drugs was significantly better (mobileMICROMEDEX t test; P = 0.05; Eprocrates Rx Pro t test; P = 0.01). Conclusion: Lexi-Drugs was found to be the most specific and complete PDA resource available to optimize medication safety by reducing potential errors associated with drug information. No resource was sufficient to address the patient safety information needs for all cases.

AB - Objectives: This study compared the potential for personal digital assistant (PDA)-based drug information sources to minimize potential medication errors dependent on accurate and complete drug information at the point of care. Methods: A quality and safety framework for drug information resources was developed to evaluate 11 PDA-based drug information sources. Three drug information sources met the criteria of the framework: Eprocrates Rx Pro, Lexi-Drugs, and mobileMICROMEDEX. Medication error types related to drug information at the point of care were then determined. Forty-seven questions were developed to test the potential of the sources to prevent these error types. Pharmacists and physician experts from Creighton University created these questions based on the most common types of questions asked by primary care providers. Three physicians evaluated the drug information sources, rating the source for each question: 1 = no information available, 2 = some information available, or 3 = adequate amount of information available. Results: The mean ratings for the drug information sources were: 2.0 (Eprocrates Rx Pro), 2.5 (Lexi-Drugs), and 2.03 (mobileMICROMEDEX). Lexi-Drugs was significantly better (mobileMICROMEDEX t test; P = 0.05; Eprocrates Rx Pro t test; P = 0.01). Conclusion: Lexi-Drugs was found to be the most specific and complete PDA resource available to optimize medication safety by reducing potential errors associated with drug information. No resource was sufficient to address the patient safety information needs for all cases.

UR - http://www.scopus.com/inward/record.url?scp=23844525727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844525727&partnerID=8YFLogxK

M3 - Article

VL - 93

SP - 229

EP - 236

JO - Journal of the Medical Library Association : JMLA

JF - Journal of the Medical Library Association : JMLA

SN - 1536-5050

IS - 2

ER -